Search Media Items

ALCHEMIST represents three integrated, precision medicine trials that are designed to identify people with early-stage lung cancer who have tumors that harbor certain uncommon genetic changes and evaluate whether drug treatments targeted against those mol

NCI has embarked on the Exceptional Responders Initiative to understand the molecular underpinnings of exceptional responses to treatment, primarily via chemotherapy, in cancer patients.

Dr. Volkow discusses how taking medicine in a way that is different from what the doctor prescribed can be dangerous.

People who share needles and syringes to inject drugs are at high risk for HIV and other infections. Syringe services programs can play a key role in prevention.

Learn more about Native American Heritage Month, the health status of this population, and some of the research CDC is doing.

Review Article. Describes recent advances in genomic science and drug response. Describes potential applications for drug selection and administration based on genomic science that may be able to reduce adverse drug reactions.

On July 1, 2014, this report was posted as an MMWR Early Release on the MMWR website (http://www.cdc.gov/mmwr).

Counterfeit medications are common in some countries. These drugs may not be effective or may be harmful. When traveling overseas, bring all medications with you.

Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.